Large-scale testing (Phase 3)Ended earlyNCT03409679What this trial is testingPivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas AeruginosaWho this might be right forPneumonia Polyphor Ltd. 41
Early research (Phase 1)Looking for participantsNCT06801223What this trial is testingAssess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex InfectionWho this might be right forAcinetobacter Baumannii-calcoaceticus Complex Infection (ABC) Innoviva Specialty Therapeutics 48
Large-scale testing (Phase 3)Study completedNCT05905055What this trial is testingP3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant EnterobacteralesWho this might be right forComplicated Urinary Tract InfectionAcute PyelonephritisHospital-acquired Bacterial Pneumonia+2 more Meiji Seika Pharma Co., Ltd. 126
Large-scale testing (Phase 3)Looking for participantsNCT07089186What this trial is testingStudy to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsWho this might be right forHospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more Qilu Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)Study completedNCT02493764What this trial is testingImipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)Who this might be right forBacterial Pneumonia Merck Sharp & Dohme LLC 537
Large-scale testing (Phase 3)Looking for participantsNCT07327619What this trial is testingEvaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPWho this might be right forHospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Qilu Pharmaceutical Co., Ltd. 420
Post-approval studies (Phase 4)Looking for participantsNCT07004049What this trial is testingOptimising TREATment for Severe Gram-Negative Bacterial InfectionsWho this might be right forBloodstream InfectionVentilator Associated Bacterial PneumoniaHospital Acquired Bacterial Pneumonia+2 more National University of Singapore 600
Testing effectiveness (Phase 2)Looking for participantsNCT07759934What this trial is testingASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaWho this might be right forVentilator-associated Bacterial Pneumonia (VABP)Hospital-acquired Bacterial Pneumonia (HABP) Jiangsu Aosaikang Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT05685615What this trial is testingPK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRABWho this might be right forVentilator Associated Pneumonia BioVersys AG 39
Testing effectiveness (Phase 2)Looking for participantsNCT06087536What this trial is testingA Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii ComplexWho this might be right forHospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia Omnix Medical Ltd 54
Not applicableStudy completedNCT02689531What this trial is testingCTTI Risk Factors for HABP/VABP StudyWho this might be right forPneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia, Hospital-Acquired Duke University 7,530
Large-scale testing (Phase 3)Study completedNCT05204563What this trial is testingImipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)Who this might be right forHospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia Evopoint Biosciences Inc. 450
Not applicableStudy completedNCT02728518What this trial is testingNebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial PneumoniaWho this might be right forPneumonia National Heart Institute, Egypt 133
Testing effectiveness (Phase 2)Looking for participantsNCT07512596What this trial is testingStudy on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaWho this might be right forHospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07634198What this trial is testingA Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaWho this might be right forHospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP) Nanjing Yoko Biomedical Co., Ltd. 590